Dhirendra Singh

Dhirendra Singh Genelife Clinical Research Pvt. Ltd. Dhirendra V. With a distinguished background in the pharmaceutical and clinical research industries, Mr. Under Mr.

Singh, the Managing Director of Genelife Clinical Research, is a visionary leader with a passion for advancing healthcare through cutting-edge clinical research and innovation. Singh brings a wealth of expertise to his role at Genelife. As Managing Director, Mr. Singh is the driving force behind the company's mission to provide cost-effective Phase I-IV clinical research services and accelerate th

e drug development process. His leadership is characterized by a commitment to excellence, transparency, and a patient-centric approach. Singh's guidance, Genelife Clinical Research has expanded its global presence, establishing a strong foothold in key regions, including India, Europe, the USA, and the UK. His strategic vision has enabled the company to adapt to regional nuances while maintaining a commitment to the broader market value. Furthermore, Mr. Singh's dedication to technological innovation is evident in Genelife's adoption of state-of-the-art tools and processes, ensuring the highest standards of quality and compliance in clinical research. As a leader in the field, Dhirendra V. Singh is instrumental in shaping Genelife Clinical Research into a trusted partner for pharmaceutical, medical device, and biologics companies seeking to drive innovation and make a positive impact on healthcare worldwide. His leadership inspires the Genelife team to continually push the boundaries of what is possible in clinical research, ultimately benefiting patients and advancing the frontiers of medicine.

13/04/2026

RWE provides insights into how drugs and therapies perform in real-world clinical settings, helping stakeholders make informed decisions.

10/04/2026

Understanding the CDSCO approval process is essential for pharmaceutical, biotechnology, and medical device companies planning to conduct clinical stu

08/04/2026

With Genelife Clinical Research Pvt. Ltd. – I just got recognized as one of their top fans!

08/04/2026

Learn the key factors for selecting a CRO in India for your clinical trials.

06/04/2026

The future of clinical trials is no longer just about science — it is about innovation, speed, and patient-centricity.

05/04/2026

Genelife, Clinical Research, GCP, Medical Device, Patient Recruitment, Asthma, Oncology, Ophthalmology, Clinical Trials, Cancer, tuberculosis

04/04/2026

Genelife, Clinical Research, GCP, Medical Device, Patient Recruitment, Asthma, Oncology, Ophthalmology, Clinical Trials, Cancer, tuberculosis

03/04/2026

Genelife, Clinical Research, GCP, Medical Device, Patient Recruitment, Asthma, Oncology, Ophthalmology, Clinical Trials, Cancer, tuberculosis

01/04/2026

Genelife, Clinical Research, GCP, Medical Device, Patient Recruitment, Asthma, Oncology, Ophthalmology, Clinical Trials, Cancer, tuberculosis

27/03/2026

Clinical research is undergoing a significant transformation, shaped by evolving regulatory expectations, rapid technological advancements, and an increasing emphasis on patient-centric approaches. Regulatory authorities across the globe are continuously refining their frameworks to ensure that clin

31/12/2025

🌟 Happy New Year from Genelife Clinical Research Pvt. Ltd. 🌟

A New Year brings new hopes, new goals, and new possibilities. As we step into the year ahead, we remain committed to scientific excellence, ethical research, and improving patient outcomes worldwide.
Thank you for being part of our journey. May the New Year be filled with good health, success, and meaningful achievements for all.
Together, let’s continue advancing healthcare through research.

Warm New Year Wishes,
Genelife Clinical Research Pvt. Ltd.

Address

Mumbai
400064

Website

Alerts

Be the first to know and let us send you an email when Dhirendra Singh posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category